Dendritic cells from Crohn's disease patients show aberrant STAT1 and STAT3 signaling.

Abnormalities of dendritic cells (DCs) and STAT proteins have been reported in Crohn's disease (CD). Studies on JAK/STAT signaling in DCs are, however, lacking in CD. We applied a flowcytometric single-cell-based phosphoepitope assay to evaluate STAT1 and STAT3 pathways in DC subsets from CD pa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Janne K Nieminen, Mirja Niemi, Taina Sipponen, Harri M Salo, Paula Klemetti, Martti Färkkilä, Jukka Vakkila, Outi Vaarala
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3bafaa11e0354d1e91441107affa76d9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3bafaa11e0354d1e91441107affa76d9
record_format dspace
spelling oai:doaj.org-article:3bafaa11e0354d1e91441107affa76d92021-11-18T09:00:47ZDendritic cells from Crohn's disease patients show aberrant STAT1 and STAT3 signaling.1932-620310.1371/journal.pone.0070738https://doaj.org/article/3bafaa11e0354d1e91441107affa76d92013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23950992/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Abnormalities of dendritic cells (DCs) and STAT proteins have been reported in Crohn's disease (CD). Studies on JAK/STAT signaling in DCs are, however, lacking in CD. We applied a flowcytometric single-cell-based phosphoepitope assay to evaluate STAT1 and STAT3 pathways in DC subsets from CD patients. In addition, circulating DC counts were determined, together with the activation-related immunophenotype. We found that IL-6- and IFN-α-induced STAT3 phosphorylation and IFN-α-induced STAT1 phosphorylation were impaired in plasmacytoid DCs (pDCs) from CD patients (P = 0.005, P = 0.013, and P = 0.006, respectively). In myeloid DCs (mDCs), IFN-α-induced STAT1 and STAT3 phosphorylation were attenuated (P<0.001 and P = 0.048, respectively), but IL-10-induced STAT3 phosphorylation was enhanced (P = 0.026). IFN-γ-induced STAT1 signaling was intact in both DC subtypes. Elevated plasma IL-6 levels were detected in CD (P = 0.004), which strongly correlated with disease activity (ρ = 0.690, P<0.001) but not with IL-6-induced STAT3 phosphorylation. The numbers of pDCs and BDCA3+ mDCs were decreased, and CD40 expression on CD1c+ mDCs was increased in CD. When elucidating the effect of IL-6 signaling on pDC function, we observed that IL-6 treatment of healthy donor pDCs affected the maturation of and modified the T-cell priming by pDCs, favoring Th2 over Th1 type of response and the expression of IL-10 in T cells. Our results implicate DC signaling in human CD. Reduced IL-6 responsiveness in pDCs, together with the attenuated IFN-α-induced signaling in both DC subtypes, may contribute to the immunological dysregulation in CD patients.Janne K NieminenMirja NiemiTaina SipponenHarri M SaloPaula KlemettiMartti FärkkiläJukka VakkilaOuti VaaralaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 8, p e70738 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Janne K Nieminen
Mirja Niemi
Taina Sipponen
Harri M Salo
Paula Klemetti
Martti Färkkilä
Jukka Vakkila
Outi Vaarala
Dendritic cells from Crohn's disease patients show aberrant STAT1 and STAT3 signaling.
description Abnormalities of dendritic cells (DCs) and STAT proteins have been reported in Crohn's disease (CD). Studies on JAK/STAT signaling in DCs are, however, lacking in CD. We applied a flowcytometric single-cell-based phosphoepitope assay to evaluate STAT1 and STAT3 pathways in DC subsets from CD patients. In addition, circulating DC counts were determined, together with the activation-related immunophenotype. We found that IL-6- and IFN-α-induced STAT3 phosphorylation and IFN-α-induced STAT1 phosphorylation were impaired in plasmacytoid DCs (pDCs) from CD patients (P = 0.005, P = 0.013, and P = 0.006, respectively). In myeloid DCs (mDCs), IFN-α-induced STAT1 and STAT3 phosphorylation were attenuated (P<0.001 and P = 0.048, respectively), but IL-10-induced STAT3 phosphorylation was enhanced (P = 0.026). IFN-γ-induced STAT1 signaling was intact in both DC subtypes. Elevated plasma IL-6 levels were detected in CD (P = 0.004), which strongly correlated with disease activity (ρ = 0.690, P<0.001) but not with IL-6-induced STAT3 phosphorylation. The numbers of pDCs and BDCA3+ mDCs were decreased, and CD40 expression on CD1c+ mDCs was increased in CD. When elucidating the effect of IL-6 signaling on pDC function, we observed that IL-6 treatment of healthy donor pDCs affected the maturation of and modified the T-cell priming by pDCs, favoring Th2 over Th1 type of response and the expression of IL-10 in T cells. Our results implicate DC signaling in human CD. Reduced IL-6 responsiveness in pDCs, together with the attenuated IFN-α-induced signaling in both DC subtypes, may contribute to the immunological dysregulation in CD patients.
format article
author Janne K Nieminen
Mirja Niemi
Taina Sipponen
Harri M Salo
Paula Klemetti
Martti Färkkilä
Jukka Vakkila
Outi Vaarala
author_facet Janne K Nieminen
Mirja Niemi
Taina Sipponen
Harri M Salo
Paula Klemetti
Martti Färkkilä
Jukka Vakkila
Outi Vaarala
author_sort Janne K Nieminen
title Dendritic cells from Crohn's disease patients show aberrant STAT1 and STAT3 signaling.
title_short Dendritic cells from Crohn's disease patients show aberrant STAT1 and STAT3 signaling.
title_full Dendritic cells from Crohn's disease patients show aberrant STAT1 and STAT3 signaling.
title_fullStr Dendritic cells from Crohn's disease patients show aberrant STAT1 and STAT3 signaling.
title_full_unstemmed Dendritic cells from Crohn's disease patients show aberrant STAT1 and STAT3 signaling.
title_sort dendritic cells from crohn's disease patients show aberrant stat1 and stat3 signaling.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/3bafaa11e0354d1e91441107affa76d9
work_keys_str_mv AT janneknieminen dendriticcellsfromcrohnsdiseasepatientsshowaberrantstat1andstat3signaling
AT mirjaniemi dendriticcellsfromcrohnsdiseasepatientsshowaberrantstat1andstat3signaling
AT tainasipponen dendriticcellsfromcrohnsdiseasepatientsshowaberrantstat1andstat3signaling
AT harrimsalo dendriticcellsfromcrohnsdiseasepatientsshowaberrantstat1andstat3signaling
AT paulaklemetti dendriticcellsfromcrohnsdiseasepatientsshowaberrantstat1andstat3signaling
AT marttifarkkila dendriticcellsfromcrohnsdiseasepatientsshowaberrantstat1andstat3signaling
AT jukkavakkila dendriticcellsfromcrohnsdiseasepatientsshowaberrantstat1andstat3signaling
AT outivaarala dendriticcellsfromcrohnsdiseasepatientsshowaberrantstat1andstat3signaling
_version_ 1718421015731634176